Jonny FinlayDirector, Protein Discovery and Optimization Pfizer
Ira PastanHead, Molecular Biology Section NCI, NIH
George GiorgiouProfessor University of Texas, Austin
Bill StrohlVice President, Biologics Research Johnson & Johnson
Understanding new discovery and engineering technologies and approaches being used by other drug developers is critical. Learning how to take them forward within your organization is priceless.
That’s where this conference comes in.
Unlike other antibody conferences, Antibody Engineering and Discovery 2013 is a meeting that doesn’t just give you a comprehensive overview and in-depth understanding and of what other drug developers are doing…
It’s also a meeting that will noticeable change the way you operate on your return to the lab, by giving you the opportunity to uncover how to use the new approaches used by your competitors. All so that you can move your own antibody pipeline forward.
With a focus on delivering results in a commercial environment, this is a meeting that will help you:
Because delivering in a commercial environment is the focus, speakers and delegates are dominated by drug developers who can tell you first-hand how to discover and develop differentiated antibodies. Presenters include heads of antibody programs from Pfizer, Novartis, Merck, AbbVie, MedImmune, Amgen and BMS.
Heavyweights of the antibody field, George Georgiou and Ira Pastan, will outline radically different discovery and engineering approaches that will help propel your development efforts forwards. Plus, the FDA will update you on their evolving regulatory expectations regarding antibody development.
Get more details of who is speaking and what’s being covered here.
So how can you be sure attending this conference becomes the best two days you spend away from the lab this year?
This is a very different type of antibody meeting. You’ve said that the quality of discussion and the usability of the knowledge you take away from the meeting is critical.
The conference will deliver information that’ll make a tangible difference to your performance when you return. A premium is placed on knowledge sharing and networking. Here’s how:
"High quality speakers, high content presentations and lots of opportunities for networking" Pfizer
“Nice agenda, top notch speakers, and great presentations and speed networking.” Aldevron
“The most profitable event we’ve ever attended.” Immunologix
“A good venue for review of the antibody engineering industry and opportunity to learn some new breakthroughs.” Abbott